355 related articles for article (PubMed ID: 15596374)
1. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.
Sirlin CB; Vera DR; Corbeil JA; Caballero MB; Buxton RB; Mattrey RF
Acad Radiol; 2004 Dec; 11(12):1361-9. PubMed ID: 15596374
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
[TBL] [Abstract][Full Text] [Related]
3. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes.
Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ
Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699
[TBL] [Abstract][Full Text] [Related]
4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
7. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight.
Desser TS; Rubin DL; Muller HH; Qing F; Khodor S; Zanazzi G; Young SW; Ladd DL; Wellons JA; Kellar KE
J Magn Reson Imaging; 1994; 4(3):467-72. PubMed ID: 8061449
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of experimental myocardial infarction.
Wikström M
Acta Radiol Suppl; 1992; 379():1-30. PubMed ID: 1317989
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
11. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
[TBL] [Abstract][Full Text] [Related]
14. Preparation of polymer-based magnetic resonance imaging contrast agent to visualize therapeutic angiogenesis.
Jo J; Lin X; Nakahara T; Aoki I; Saga T; Tabata Y
Tissue Eng Part A; 2013 Jan; 19(1-2):30-9. PubMed ID: 22838390
[TBL] [Abstract][Full Text] [Related]
15. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
[TBL] [Abstract][Full Text] [Related]
16. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
17. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
Wang X; Feng Y; Ke T; Schabel M; Lu ZR
Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
[TBL] [Abstract][Full Text] [Related]
19. Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent.
Schwickert HC; Roberts TP; Mühler A; Stiskal M; Demsar F; Brasch RC
Eur J Radiol; 1995 Jul; 20(2):144-50. PubMed ID: 7588870
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]